Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cho

Showing results (811-820 of 1,046) with videos related to

Pageof 105
Sort By:
Oncogene|September 26, 2017
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinomaM R Yun, H M Choi, H N Kang, et al.
Plos Neglected Tropical Diseases|October 7, 2022
Proteomic profiling of serum extracellular vesicles identifies diagnostic markers for echinococcosisXiaola Guo, Shuai Wang, Junmei Zhang, et al.
ESMO Open|September 24, 2025
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter studyP Schöffski, A Gazzah, J Trigo, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2023
Deep learning-based solid component measuring enabled interpretable prediction of tumor invasiveness for lung adenocarcinomaJiajing Sun, Li Zhang, Bingyu Hu, et al.
Cytogenetic and Genome Research|January 5, 2005
Assignment of phosphatidylinositol glycan, class K (PIGK) gene to porcine chromosome 6q32 by somatic cell and radiation hybrid panel mappingE W Park, J H Kim, H T Lim, et al.
Frontiers in Pharmacology|September 9, 2022
Lung adenocarcinoma-related target gene prediction and drug repositioningRui Xuan Huang, Damrongrat Siriwanna, William C Cho, et al.
Oxidative Medicine and Cellular Longevity|September 29, 2021
Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related DiseasesCristina Quispe, Natália Cruz-Martins, Maria Letizia Manca, et al.
Journal of the Royal Society, Interface|June 6, 2019
An electro-osmotic microfluidic system to characterize cancer cell migration under confinementT H Hui, W C Cho, H W Fong, et al.
Cancer|April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictorC H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Biomolecules|November 28, 2019
Liposomal Cytarabine as Cancer Therapy: From Chemistry to MedicineBahare Salehi, Zeliha Selamoglu, Ksenija S Mileski, et al.
Pageof 105

Showing results (811-820 of 1,046) with videos related to

Sort By:
Pageof 105
Oncogene|September 26, 2017
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinomaM R Yun, H M Choi, H N Kang, et al.
Plos Neglected Tropical Diseases|October 7, 2022
Proteomic profiling of serum extracellular vesicles identifies diagnostic markers for echinococcosisXiaola Guo, Shuai Wang, Junmei Zhang, et al.
ESMO Open|September 24, 2025
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter studyP Schöffski, A Gazzah, J Trigo, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2023
Deep learning-based solid component measuring enabled interpretable prediction of tumor invasiveness for lung adenocarcinomaJiajing Sun, Li Zhang, Bingyu Hu, et al.
Cytogenetic and Genome Research|January 5, 2005
Assignment of phosphatidylinositol glycan, class K (PIGK) gene to porcine chromosome 6q32 by somatic cell and radiation hybrid panel mappingE W Park, J H Kim, H T Lim, et al.
Frontiers in Pharmacology|September 9, 2022
Lung adenocarcinoma-related target gene prediction and drug repositioningRui Xuan Huang, Damrongrat Siriwanna, William C Cho, et al.
Oxidative Medicine and Cellular Longevity|September 29, 2021
Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related DiseasesCristina Quispe, Natália Cruz-Martins, Maria Letizia Manca, et al.
Journal of the Royal Society, Interface|June 6, 2019
An electro-osmotic microfluidic system to characterize cancer cell migration under confinementT H Hui, W C Cho, H W Fong, et al.
Cancer|April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictorC H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Biomolecules|November 28, 2019
Liposomal Cytarabine as Cancer Therapy: From Chemistry to MedicineBahare Salehi, Zeliha Selamoglu, Ksenija S Mileski, et al.
Pageof 105